(E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole

C22H23N5O4 — CID 162339514

IUPAC(E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole
SMILESCN1C[C@@H]2CN(c3ccc(-c4c[nH]c5ccccc45)nn3)C[C@@H]21.O=C(O)/C=C/C(=O)O
InChIInChI=1S/C18H19N5.C4H4O4/c1-22-9-12-10-23(11-17(12)22)18-7-6-16(20-21-18)14-8-19-15-5-3-2-4-13(14)15;5-3(6)1-2-4(7)8/h2-8,12,17,19H,9-11H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t12-,17+;/m1./s1
InChIKeyDTXKAZBITYXMCG-AIMKETPSSA-N
MW421.46 g/mol
LogP2.09
Rot. Bonds4

About (E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole

(E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole (PubChem CID 162339514) has the molecular formula C22H23N5O4 and a molecular weight of 421.46 g/mol. Its IUPAC name is (E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole.

Molecular Properties

Compound Name(E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole
PubChem CID162339514
Molecular FormulaC22H23N5O4
Molecular Weight421.46 g/mol
Exact Mass421.18
IUPAC Name(E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole
SMILESCN1C[C@@H]2CN(c3ccc(-c4c[nH]c5ccccc45)nn3)C[C@@H]21.O=C(O)/C=C/C(=O)O
InChIInChI=1S/C18H19N5.C4H4O4/c1-22-9-12-10-23(11-17(12)22)18-7-6-16(20-21-18)14-8-19-15-5-3-2-4-13(14)15;5-3(6)1-2-4(7)8/h2-8,12,17,19H,9-11H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t12-,17+;/m1./s1
InChIKeyDTXKAZBITYXMCG-AIMKETPSSA-N
XLogP2.09
TPSA122.65 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500421.46
LogP ≤ 52.09
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole?
The IUPAC name of (E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole (CID 162339514) is (E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole.
What is the SMILES notation for (E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole?
The canonical SMILES for (E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole is CN1C[C@@H]2CN(c3ccc(-c4c[nH]c5ccccc45)nn3)C[C@@H]21.O=C(O)/C=C/C(=O)O.
What is the InChIKey of (E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole?
The InChIKey is DTXKAZBITYXMCG-AIMKETPSSA-N. The full InChI is InChI=1S/C18H19N5.C4H4O4/c1-22-9-12-10-23(11-17(12)22)18-7-6-16(20-21-18)14-8-19-15-5-3-2-4-13(14)15;5-3(6)1-2-4(7)8/h2-8,12,17,19H,9-11H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t12-,17+;/m1./s1.
What are the key properties of (E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole?
(E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole has a molecular weight of 421.46 g/mol, XLogP of 2.09, 4 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-but-2-enedioic acid;3-[6-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]pyridazin-3-yl]-1H-indole is sourced from PubChem (CID 162339514), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).